<!DOCTYPE html>
<html>
<head>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="">
    <meta name="description" content="">
    <title>详细报告语句详情</title>
    <link href="../css/bootstrap.css" rel="stylesheet" />
    <link href="../css/style.css" rel="stylesheet" />
    <style type="text/css">
        .content-tips .paper-section{margin-bottom:0;min-width:450px;}
    </style>
</head>
<body>
<span id="gototop"></span>
<div>
    <div class="paper-txt P30">
        <div class="paper-section" style="margin-bottom:0;">
            <div class="font-bold MT5">
                该句相似度：<span class="g-font-color orange similarNum">45%</span>
            </div>
            <div class="MT30">
                <p class="font-bold">您的语句：</p>
                <span>贝伐珠单抗和多西他赛，5-FU，吉西他滨、紫杉醇等二线单药治疗。</span>
            </div>
        </div>
    </div>
    <div>
        <div class="tab-A">
            <ul class="tab-A-ul clearfix" tab-a="ul">
                <li class="active" data-id="学术期刊,学位论文,学术会议,书籍数据,互联网,自建库,all">
                    <span class="tab-text">综合</span>
                    <span class="tab-superscript">12</span>
                </li>
                <li data-id="tab,学术期刊,学位论文,学术会议,书籍数据,自建库,local">
                    <span class="tab-text">本地库</span>
                    <span class="tab-superscript">12</span>
                </li>
                <li data-id="互联网,5">
                    <span class="tab-text">互联网</span>
                    <span class="tab-superscript">0</span>
                </li>
            </ul>
        </div>
        <div class="none" tab="section" data-id="tab">
            <div class="tab-B clearfix">
                <div class="paper-section P30 PB0 clearfix">
                    <span class="tab-B-span pull-left">本地库</span>
                    <ul class="tab-B-ul pull-left clearfix" tab-b="ul">
                        <li class="active" data-id="tab,学术期刊,学位论文,学术会议,书籍数据,自建库,local">
                            <span class="tab-text">全部</span>
                            <span class="tab-superscript">12</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,学术期刊,1">
                            <span class="tab-text">期刊</span>
                            <span class="tab-superscript">2</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,学位论文,2">
                            <span class="tab-text">学位</span>
                            <span class="tab-superscript">5</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,学术会议,3">
                            <span class="tab-text">会议</span>
                            <span class="tab-superscript">3</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,书籍数据,4">
                            <span class="tab-text">图书</span>
                            <span class="tab-superscript">2</span>
                                                    </li>
                                            </ul>
                </div>
                <div class="g-line-row MT30 tab-pane-line"></div>
            </div>
        </div>
        <div class="content-tips">
            <div class="tab-content none" tab="section" data-id="1">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在期刊库共找出相似内容：<span>2</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>
                    </div>
                </div>
            </div>

            <div class="tab-content none" tab="section" data-id="2">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在学位库共找出相似内容：<span>5</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>                    </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="3">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在会议库共找出相似内容：<span>3</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>                    </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="4">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在图书库共找出相似内容：<span>2</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>                    </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="5">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在互联网库中没有找到与此句话相似的内容                    <p>
                    <div class="pull-right">
                                            </div>
                </div>
            </div>
            <!-- 自建库 -->
            <div class="tab-content none" tab="section" data-id="6">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在自建库中没有找到与此句话相似的内容                    <p>
                    <div class="pull-right">
                                            </div>
                </div>
            </div>
                        <div class="tab-content" tab="section" data-id="all">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在本地库和互联网库共找出相似内容：<span>12</span>个
                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>

                    </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="local">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在本地库共找出相似内容：<span>12</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>
                    </div>
                </div>
            </div>
        </div>



                <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">1</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">45%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange"><span class="g-underline-text">贝</span><span class="g-underline-text">伐</span>珠<span class="g-underline-text">单</span><span class="g-underline-text">抗</span>和多西<span class="g-underline-text">他</span>赛，5-FU，<span class="g-underline-text">吉西</span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、紫杉醇等二线<span class="g-underline-text">单</span>药治疗。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">、<span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span>与<span class="g-underline-text">吉西</span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、5-FU、奥沙利铂或卡培<span class="g-underline-text">他</span><span class="g-underline-text">滨</span>的联合化疗</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            单抗、贝伐单抗、马立马司他和tanomastat对进展期胰腺癌患者总体生存期无改善[27]。目前已完成马立马司他、tanomastat、吉妥单抗、厄洛替尼、西妥昔单抗<span class="g-font-color green">、贝伐单抗与吉西他滨、5-FU、奥沙利铂或卡培他滨的联合化疗</span>临床二期试验，部分进入临床三期试验吉妥单抗是靶向法尼基转移酶的非硫基、非                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《肿瘤标志物在胰腺良恶性疾病鉴别诊断中的临床应用》<br><b>作者：</b>孙罡<br><b>分类号：</b>R735.9<br><b>学科专业：</b>内科学(消化系病)<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>王立夫<br><b>学位授予单位：</b>上海交通大学<br><b>学位年度：</b>2009<br><b>关键词：</b>肿瘤标志物 胰腺良恶性疾病 鉴别诊断 临床应用 胰腺癌
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术会议">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">2</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">44%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange"><span class="g-underline-text">贝</span><span class="g-underline-text">伐</span>珠<span class="g-underline-text">单</span><span class="g-underline-text">抗</span>和多西<span class="g-underline-text">他</span>赛，5-FU，<span class="g-underline-text">吉西</span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、紫杉醇等二线<span class="g-underline-text">单</span>药治疗。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span>+<span class="g-underline-text">吉西</span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>+5-FU进展期Ⅱ<span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span>+<span class="g-underline-text">吉西</span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>+草酸铂</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            贝伐单抗+厄罗替尼局部进展期转移性ⅡC，enistein+吉西他滨+厄罗替尼进展期或转移性Ⅱ吉西他滨+卡培他宾+贝伐单抗转移性或不可切除Ⅱ<span class="g-font-color green">贝伐单抗+吉西他滨+5-FU进展期Ⅱ贝伐单抗+吉西他滨+草酸铂</span>转移性Ⅱ吉西他滨+顺铂+贝伐单抗转移性ⅡC．225+吉西他滨+草酸铂                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术会议）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《胰腺癌的内科治疗--从化疗到分子靶向治疗》<br><b>作者：</b>刘平 束永前<br><b>作者单位：</b>南京医科大学第一附属医院肿瘤科,南京 210029<br><b>会议名称：</b>第二届“CSCO-南方”肿瘤生物治疗与分子靶向治疗论坛、第一届循证医学与肿瘤规范化诊疗研讨会暨第七届全国肿瘤综合诊疗新进展研讨会<br><b>主办单位：</b>广东省中西医结合学会<br><b>会议时间：</b>2008-08-01<br><b>会议地点：</b>广州<br><b>关键词：</b>胰腺癌 分子靶向治疗 化学疗法 临床试验
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术期刊">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">3</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">44%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange"><span class="g-underline-text">贝</span><span class="g-underline-text">伐</span>珠<span class="g-underline-text">单</span><span class="g-underline-text">抗</span><span class="g-underline-text">和</span><span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>，5-FU，吉<span class="g-underline-text">西</span><span class="g-underline-text">他</span>滨、紫杉醇等二线<span class="g-underline-text">单</span>药治疗。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span>联合<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span><span class="g-underline-text">和</span><span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span><span class="g-underline-text">单</span>药组。结果显示，<span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span></p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            单抗治疗晚期NSCLC的另一项研究热点为贝伐单抗用于跨线治疗是否有效。日本的一项Ⅱ期多中心随机对照研究，将经过一线贝伐单抗联合含铂化疗方案失败的患者随机分配至<span class="g-font-color green">贝伐单抗联合多西他赛和多西他赛单药组。结果显示，贝伐单抗</span>的继续使用有提高患者的PFS（4.4个月vs.3.4个月）和OS（13.                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术期刊）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《贝伐单抗治疗晚期非小细胞肺癌的疗效与安全性临床研究进展》<br><b>作者：</b>胡彬彬 陈宝清 卢铀<br><b>作者单位：</b>四川大学华西临床医学院 成都市610041；四川大学华西医院胸部肿瘤科<br><b>参考文献：</b>46篇<br><b>页码：</b>P129—P135<br><b>页数：</b>7页<br><b>基金项目：</b>本文课题受国家自然科学基金项目(编号81472196)资助This work was supported by the National Natural Science Foundation of China(81472196)<br><b>期刊名称：</b>《中国肿瘤临床》<br><b>出版时间：</b>2017年3期<br><b>期刊级别：</b>ISTIC - PKU<br><b>ISSN：</b>1000-8179<br><b>关键词：</b>非小细胞肺癌 贝伐单抗 化学治疗 靶向治疗 维持治疗 安全性<br><b>摘要：</b>抗血管生成治疗是肿瘤常见的治疗方式之一。贝伐单抗作为抗血管内皮生长因子的单克隆抗体，是目前唯一被批准用于晚期非小细胞肺癌（non-small cell lung cancer，NSCLC）一线治疗的抗血管生成制剂。为了扩大贝伐单抗用于晚期NSCLC的适应证，大量研究继续探索贝伐单抗在一线治疗的联合形式外，还致力于探索其在后线及跨线治疗的疗效和安全性。本文就近年来贝伐单抗用于晚期NSCLC治疗的疗效与安全性临床研究进展进行综述。
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="书籍数据">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">4</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">43%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">贝伐珠单抗<span class="g-underline-text">和</span><span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>，5-FU，<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>等二线单药<span class="g-underline-text">治疗</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">卡培<span class="g-underline-text">他</span><span class="g-underline-text">滨</span>联合<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>）<span class="g-underline-text">和</span>GT（<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>联合<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>）方案。<span class="g-underline-text">紫杉</span>类<span class="g-underline-text">治疗</span>失败</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            失败的患者；部分辅助治疗用过蒽环类和（或）紫杉类，但临床未判定为耐药和治疗失败的患者也可使用AT方案。蒽环类辅助治疗失败的患者可以选择的方案有XT（<span class="g-font-color green">卡培他滨联合多西他赛）和GT（吉西他滨联合紫杉醇）方案。紫杉类治疗失败</span>的患者目前尚无标准方案推荐，可以考虑使用卡培他滨、长春瑞滨、吉西他滨和铂类                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（书籍数据）：</p>
                            <div class="local-source-detail">
                                <b>章节：</b>《第三章 乳腺癌骨转移》<br><b>书名：</b>《恶性肿瘤骨转移的诊断与治疗》<br><b>作者：</b>于世英<br><b>出版社：</b>中国协和医科大学出版社<br><b>出版时间：</b>2012-04-01<br><b>ISBN：</b>978-7-81136-576-4<br><b>摘要：</b>本书内容包括：恶性肿瘤骨转移概论；肺瘤骨转移；乳腺癌骨转移；前列腺癌骨转移等。
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术期刊">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">5</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">43%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange"><span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">珠</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span>和<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>，5-FU，吉<span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、紫杉醇等二线<span class="g-underline-text">单</span>药<span class="g-underline-text">治疗</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">珠</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span>联合<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>及卡培<span class="g-underline-text">他</span><span class="g-underline-text">滨</span>方案<span class="g-underline-text">治疗</span>。<span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">珠</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span>15mg</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            肝转移。既往一线化疗使用过蒽环类10例、紫杉醇8例和吉西他滨2例，其中使用紫衫类药物距离本次入组时间至少一年。1．2治疗方法20例转移性TNBC患者均接受<span class="g-font-color green">贝伐珠单抗联合多西他赛及卡培他滨方案治疗。贝伐珠单抗15mg</span>/kg静滴，第ld；多西他赛75mg/m2静滴，第个周期。多西他                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术期刊）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《贝伐单抗联合多西他赛和卡培他滨二线治疗转移性三阴性乳腺癌的临床研究》<br><b>作者：</b>贺小停 刘超英<br><b>作者单位：</b>南京医科大学附属无锡市人民医院 肿瘤科,江苏无锡,214023<br><b>参考文献：</b>16篇<br><b>页码：</b>P35—P38<br><b>页数：</b>4页<br><b>分类号：</b>R979.1<br><b>期刊名称：</b>《医疗装备》<br><b>出版时间：</b>2014年11期<br><b>ISSN：</b>1002-2376<br><b>关键词：</b>贝伐单抗 多西他赛 卡培他滨 三阴性乳腺癌<br><b>摘要：</b>目的:回顾性分析贝伐单抗联合多西他赛和卡培他滨二线治疗三阴性乳腺癌的临床疗效及安全性.方法:转移性三阴性乳腺癌女性患者均经病理证实,患者至少存在一个可行RECIST1.1评估的病灶,既往使用过蒽环类、紫杉醇或吉西他滨等一线化疗,其中接受过紫杉类治疗的间隔一年以上.贝伐单抗15mg/kg,多西他赛75mg/m2,卡培他滨1.5口服2次/d,1～14d,3周重复.每个患者至少接受两个周期的化疗,每个周期后评估毒副反应,每两个周期后评价疗效,按RECIST1.1标准分为完全缓解(RR),部分缓解((PR),稳定(SD)和进展(PD),其中疾病控制率(DCR) =RR+PR +SD.结果:20例三阴性乳腺癌患者入组,没有观察到RR的病例,PR为50％ (n=10),SD为25％(n=5),PD25％ (n=5),DCR为75％.主要的毒副反应是骨髓抑制,其中Ⅲ/Ⅳ级中粒细胞减少15例(75％),粒细胞减少性发热2例(10％);1级高血压2例,2级高血压1例(15％);2级蛋白尿1例(5％);1级口腔黏膜出血1例(5％),没有观察到消化道穿孔、中枢神经系统出血等严重并发症.结论:贝伐单抗联合多西他赛和卡培他滨二线治疗转移性三阴性乳腺癌可获得较好疗效且毒副反应可耐受.
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">6</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">43%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">贝伐珠单抗和<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>，5-FU，<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>等二线单药治疗。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">化研究（<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>与<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>+卡培<span class="g-underline-text">他</span><span class="g-underline-text">滨</span>，<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>与<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>+<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span></p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            瑞滨。如果之前使用过蒽环类+紫杉类则用卡培他滨、长春瑞滨、纳米白蛋白紫杉醇或聚乙二醇脂质体阿霉素。一项从1996年开始包括996例患者情况的荟萃分析和两个随机<span class="g-font-color green">化研究（多西他赛与多西他赛+卡培他滨，紫杉醇与紫杉醇+吉西他</span>滨）比较单药化疗与联合化疗。结果显示联合化疗的疗效优于单药化疗（DVSDC为30%：42%、                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《乳腺癌术后局部复发研究进展》<br><b>作者：</b>陈春春<br><b>学科专业：</b>肿瘤学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>许培权<br><b>学位授予单位：</b>蚌埠医学院<br><b>学位年度：</b>2013
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术会议">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">7</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">43%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange"><span class="g-underline-text">贝</span><span class="g-underline-text">伐</span>珠<span class="g-underline-text">单</span><span class="g-underline-text">抗</span>和<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span>赛，5-FU，吉<span class="g-underline-text">西</span><span class="g-underline-text">他</span>滨、<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>等二线<span class="g-underline-text">单</span>药治疗。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span>10例，<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span>塞+<span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span>4例，<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>+<span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span></p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            11例。25例病例(占71．4%)经过EGFRTl(I的治疗。2．2治疗完成情况单药+贝伐单抗25例，其中培美曲赛+贝伐单抗8例，长春瑞滨+<span class="g-font-color green">贝伐单抗10例，多西他塞+贝伐单抗4例，紫杉醇+贝伐单抗</span>2例，吉西他滨+贝伐单抗1例；联合化疗+贝伐单抗10例，其中培美                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术会议）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《贝伐单抗联合化疗治疗晚期多程治疗失败后的非小细胞肺癌临床观察》<br><b>作者：</b>黄诚 张晶 柯明耀 倪敏 吴标 蒋侃 徐振武<br><b>机标分类号：</b>R73 R74<br><b>会议名称：</b>中国抗癌学会肺癌专业委员会第十二届全国肺癌学术大会<br><b>主办单位：</b>中国抗癌学会肺癌专业委员会<br><b>会议时间：</b>2011-10-27<br><b>会议地点：</b>武汉<br><b>关键词：</b>贝伐单抗 非小细胞肺癌 联合化疗
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">8</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">42%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">贝伐珠单抗和<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>，5-FU，吉<span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>等二线单药<span class="g-underline-text">治疗</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">如NCCN指南推荐的<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>联合卡培<span class="g-underline-text">他</span><span class="g-underline-text">滨</span>和吉<span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>联合<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>联合方案的<span class="g-underline-text">治疗</span>。</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            大、须快速控制症状的患者仍需选择联合化疗。在辅助/新辅助治疗中已经应用过蒽环类药物的患者中，考虑到蒽环类累积剂量心脏毒性的影响，可以首选紫杉类药物的方案，<span class="g-font-color green">如NCCN指南推荐的多西他赛联合卡培他滨和吉西他滨联合紫杉醇联合方案的治疗。</span>这两个方案已经在临床上广泛应用，注册临床试验分别在2002年和2008年的JCO杂志上发表，两                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《卡培他滨单药或联合方案治疗复发转移性乳腺癌临床疗效观察》<br><b>作者：</b>李杰<br><b>分类号：</b>R730.53<br><b>学科专业：</b>肿瘤学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>杨黎<br><b>学位授予单位：</b>贵阳医学院<br><b>学位年度：</b>2015<br><b>关键词：</b>乳腺癌 卡培他滨 临床疗效 毒副反应 复发转移 联合方案 紫衫类化疗
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="书籍数据">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">9</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">42%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">贝伐珠单抗和多<span class="g-underline-text">西</span><span class="g-underline-text">他</span>赛，5-FU，<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>等二线单药治疗。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">为4.5个月。<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>联合<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>、<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>联合<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>每周方案和<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span></p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            研究现状我国医科院肿瘤医院、军事医学科学院附属医院报道了吉西他滨联合顺铂二线解救蒽环类耐药的转移性乳腺癌的研究结果，可见临床缓解率为42.6%，中位肿瘤进展时间<span class="g-font-color green">为4.5个月。吉西他滨联合紫杉醇、吉西他滨联合紫杉醇每周方案和吉西他滨</span>联合多西紫杉醇每周方案对蒽环类耐受的转移性乳腺癌的对照研究。结果可见，3组                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（书籍数据）：</p>
                            <div class="local-source-detail">
                                <b>章节：</b>《第十章 乳腺癌的化疗》<br><b>书名：</b>《乳腺癌的临床诊疗与护理》<br><b>作者：</b>张刚, 李中, 陈保平<br><b>出版社：</b>中国科学技术出版社<br><b>出版时间：</b>2006-06-01<br><b>ISBN：</b>7-5046-4406-4<br><b>摘要：</b>本书从乳腺的临床应用解剖与生理到乳腺癌的病理、诊断、鉴别诊断、治疗及护理，比较全面系统地介绍了乳腺癌临床诊治过程中所需了解的知识。重点阐述了乳腺癌的临床诊断、治疗与护理。
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">10</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">41%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">贝伐珠<span class="g-underline-text">单</span>抗和<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>，5-FU，吉<span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、紫杉醇等二线<span class="g-underline-text">单</span>药治疗。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">滨</span>、<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span>联合铂类、<span class="g-underline-text">多</span><span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">赛</span><span class="g-underline-text">单</span>药、卡培<span class="g-underline-text">他</span><span class="g-underline-text">滨</span><span class="g-underline-text">单</span>药四组间</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            1．118例蒽环类耐药晚期乳腺癌患者总体客观缓解率为33．1%，疾病控制率为78．8%，无进展生存期为5．1个月。2．多西他赛联合卡培他<span class="g-font-color green">滨、多西他赛联合铂类、多西他赛单药、卡培他滨单药四组间</span>客观缓解率、疾病控制率均无差别。多西他赛联合卡培他滨、多西他赛联合铂                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《118例蒽环类耐药晚期乳腺癌的化疗疗效及预后分析》<br><b>作者：</b>李萌<br><b>分类号：</b>R730.53<br><b>学科专业：</b>肿瘤学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>高亚杰<br><b>学位授予单位：</b>大连医科大学<br><b>学位年度：</b>2012<br><b>关键词：</b>乳腺肿瘤 蒽环类耐药 化学疗法 临床疗效 预后因素
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">11</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">41%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange"><span class="g-underline-text">贝</span><span class="g-underline-text">伐</span>珠<span class="g-underline-text">单</span><span class="g-underline-text">抗</span><span class="g-underline-text">和</span>多<span class="g-underline-text">西</span><span class="g-underline-text">他</span>赛，5-FU，吉<span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>等二线<span class="g-underline-text">单</span>药治疗。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span><span class="g-underline-text">和</span><span class="g-underline-text">西</span>妥昔<span class="g-underline-text">单</span><span class="g-underline-text">抗</span>。<span class="g-underline-text">贝</span><span class="g-underline-text">伐</span><span class="g-underline-text">单</span><span class="g-underline-text">抗</span>联合<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>/卡铂<span class="g-underline-text">和</span>吉<span class="g-underline-text">西</span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>/</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            ；抗血管内皮生长因子(VEGF)如贝伐单抗(bevacizumab，Av嬲tm)等。近年许多III期临床研究探讨了靶向药物联合化疗的疗效，多数研究是以失败而结束，其中取得成功的仅有<span class="g-font-color green">贝伐单抗和西妥昔单抗。贝伐单抗联合紫杉醇/卡铂和吉西他滨/</span>顺铂一线治疗晚期非鳞癌NSCLC患者分别取得了OS和PFS的改善。近期研究【6】表明，化疗联合                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《多西他赛和长春瑞滨联合顺铂治疗晚期非小细胞肺癌的对比研究》<br><b>作者：</b>苏菁<br><b>分类号：</b>R730.53<br><b>学科专业：</b>内科学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>胡雪君<br><b>学位授予单位：</b>中国医科大学<br><b>学位年度：</b>2010<br><b>关键词：</b>晚期非小细胞肺癌 多西他赛 长春瑞滨 顺铂 化学疗法
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术会议">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">12</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">41%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">贝伐珠单抗和多<span class="g-underline-text">西</span><span class="g-underline-text">他</span>赛，5-FU，<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span>等二线单药<span class="g-underline-text">治疗</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">、<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>、<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>联合长春瑞<span class="g-underline-text">滨</span>和<span class="g-underline-text">吉<span class="g-underline-text">西</span></span><span class="g-underline-text">他</span><span class="g-underline-text">滨</span>联合<span class="g-underline-text">紫杉</span><span class="g-underline-text">醇</span><span class="g-underline-text">治疗</span>，4组mPFS(3</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            性。尽管研究设计时每组病例数为120例，但对前120例进行中期分析时，发现联合组相对单药组半年及1年生存优势，毒性反应两组无明显差别，因此提前结束试验接受紫杉醇<span class="g-font-color green">、吉西他滨、吉西他滨联合长春瑞滨和吉西他滨联合紫杉醇治疗，4组mPFS(3</span>.3mvs53%vs60%）的结果显示联合用药组优于单药组。联合用药组MST9.2m                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术会议）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《老年进展性非小细胞肺癌的化疗策略》<br><b>作者：</b>张越<br><b>作者单位：</b>吉林省肿瘤医院<br><b>机标分类号：</b>TP3 R96<br><b>会议名称：</b>第13届全国肺癌学术大会<br><b>主办单位：</b>中国抗癌协会<br><b>会议时间：</b>2013-08-08<br><b>会议地点：</b>长春
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
            
        <!--语句修改建议-->
        <span id="modify_suggest"></span>
        <div id="advice">
            <div class="g-line-row"></div>
            <div class="paper-txt P30 PB0">
                <div class="paper-section">
                    <p class="g-font-s16 font-bold g-font-color green MB10">该句修改建议（轻度相似，请酌情修改）</p>
                    <span class="g-font-color green"><span class="g-font-color red">贝</span><span class="g-font-color red">伐</span>珠<span class="g-font-color red">单</span><span class="g-font-color red">抗</span>和多西他赛，5-FU，<span class="g-font-color red">吉西</span>他<span class="g-font-color red">滨</span>、紫杉醇等二线<span class="g-font-color red">单</span>药治疗。</span>
                    <div class="MT10">
                        <p class="font-bold">同义词：</p>
                        <ul class="local-source-detail">
                            
                        </ul>

                    </div>
                </div>
            </div>
        </div>
    </div>
    <div class="back-to-top text-center">
        <a href="#gototop" class="font-bold g-font-color green">回到顶部</a>
    </div>
    <div class="paper-footer">
        <p>检测报告由<a href="http://www.paperpass.com/" target="_black">PaperPass</a>文献相似度检测系统生成</p>
        <p>Copyright © 2007-2018 PaperPass</p>
    </div>
</div>
</body>
<script type="text/javascript" src="../js/jquery.min.js"></script>
<script type="text/javascript" src="../js/Lib.js"></script>
<script type="text/javascript">
    (function(System,$){
        var tab = System.Paper.tab();
        var $advice = null;
        function run(){
            var i = 0;
            $advice.show();
            tab.call(this,{callback:function(){
                var $num = $(this).find('.chapter-num');
                if($num.length>0){
                    i++;
                    $num.text(i);
                }
            }});
            //没有内容时同时不显示该句修改建议
            if(0 === i){$advice.hide();}
        }
        $(function(){
            $advice = $('#advice');
            $(document).on('click','[tab-a="ul"] li',function(){
                run.call(this);
            });
            $(document).on('click','[tab-b="ul"] li',function(){
                run.call(this);
            });
        });
    })(Report,jQuery);


</script>
</html>
